BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15108364)

  • 1. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
    Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
    J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
    Zhao C; Chen Y; Park J; Kim JB; Tang H
    Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV trans-activation and transcription control mechanisms.
    Jones KA
    New Biol; 1989 Nov; 1(2):127-35. PubMed ID: 2562218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor.
    Dreikhausen U; Hiebenthal-Millow K; Bartels M; Resch K; Nourbakhsh M
    Mol Cell Biol; 2005 Sep; 25(17):7473-83. PubMed ID: 16107696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.
    Moriuchi M; Moriuchi H; Margolis DM; Fauci AS
    J Immunol; 1999 May; 162(10):5986-92. PubMed ID: 10229837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
    J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
    Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
    J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes.
    Chipitsyna G; Sawaya BE; Khalili K; Amini S
    J Cell Physiol; 2006 Jun; 207(3):605-13. PubMed ID: 16511829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
    Luo Q; Li J; Cenkci B; Kretzner L
    Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat mediates transcriptional activation of HIV-1 gene in vitro.
    West M; Hoover T; Kung H; Raziuddin
    Indian J Biochem Biophys; 1995 Dec; 32(6):351-5. PubMed ID: 8714203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
    Quivy V; De Walque S; Van Lint C
    Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the HIV-1 LTR as a promoter of negative sense transcription.
    Bentley K; Deacon N; Sonza S; Zeichner S; Churchill M
    Arch Virol; 2004 Dec; 149(12):2277-94. PubMed ID: 15338321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element.
    Margolis DM; Ostrove JM; Straus SE
    Virology; 1993 Jan; 192(1):370-4. PubMed ID: 8390764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathways.
    Tardif MR; Tremblay MJ
    J Virol; 2005 Apr; 79(7):4316-28. PubMed ID: 15767432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
    Bohne J; Kräusslich HG
    FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
    Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
    EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat.
    Bharucha DC; Zhou M; Nekhai S; Brady JN; Shukla RR; Kumar A
    Virology; 2002 Apr; 296(1):6-16. PubMed ID: 12036313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
    Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
    Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.